Dr. Sangu Komal Govind

APID

6651

ORCID

0000-0003-3419-132X

Scopus

57218667887

Google Scholar

crqeOSEAAAAJ

Location

NAVI MUMBAI, Maharashtra, India

Expertise

MEDICINAL CHEMISTRY, PHARMACEUTICAL CHEMISTRY

Areas of interest

MEDICINAL CHEMISTRY, PHARMACEUTICAL CHEMISTRY

Member since

May 2024

Biography

Researcher and academician with expertise in Medicinal chemistry, Pharmaceutical Chemistry, Drug discovery and development, Synthetic organic chemistry

Publications

1. Kaul. G., Akhir. A., Shukla. M., Komal G. Sangu., Haridas B. Rode and Siddharth Chopra., Nitazoxanide potentiates linezolid against linezolid-resistant Staphylococcus aureus in vitro and in vivo. J. Antimicrob. Chemother. 2022, 77, 2456-2460.
2. Komal G. Sangu, Naveen Kotla, Dr. T. D. Neelima. Oxidative dearomatization strategy for facile metal-free synthesisof vanillyl benzodiazepines. chemistrySelect, 2020.
3. Komal G. Sangu, Saiprasad D. varakala, Vamshi Krishna E, Haridas B. Rode., Synthesis and evaluation of GR135486X derivatives as potent antibacterial agents against Mycobacterium tuberculosis ChemistrySelect. 2023, 8, e202204186.
4. Komal G. Sangu., Akash U. Shinde, Siddharth Chopra, Haridas B. Rode., Evading Antimicrobial Resistance using Boron containing therapeutics. Fut. Med. Chem. 2020, 13, 229-232.
5. Oluyori. A.P., Harini. T., Komal G. Sangu., Krishna. E.V., Jadav. S.S., Misra. S. and Rode, H.B., 2022. Synthesis and evaluation of novel almazole D analogs as anticancer agents. Arch. Pharm. 2022, 355, 2200102.
6. Uttam B. Karale, Dattatraya Babar, Akash U. Shinde, Komal G. Sangu, Siva Krishna V, Vamshi Krishna E, Haridas B. Rode., 3- Aryl substituted imidazo[1,2-a]pyridines as antituberculosis agents. Arch. Pharm. 2021, 354, 2000419.